Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo BonaventuraDepartment of Internal Medicine, ASST dei Sette Laghi, Varese, Italy. [email protected]Alessandra VecchiéDepartment of Internal Medicine, ASST dei Sette Laghi, Varese, ItalyLorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, ItalyKimberly MartinodCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, BelgiumDave L. DixonDepartment of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USABenjamín Van TassellDepartment of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USAFrancesco DentaliDepartment of Medicine and Surgery, Insubria University, Varese, ItalyFabrizio MontecuccoFirst Clinic of Internal Medicine, Department of Internal Medicine and Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, ItalySteffen MaßbergDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Partner Site Munich Heart Alliance, Munich, GermanyMarcel LeviDepartment of Medicine and Cardio-metabolic Programme - NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust, London, UKAntonio AbbatePauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA
2021en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0